2-(4-Carboxyphenyl)-5-(4-chlorophenyl)oxazole | 108783-77-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-(4-Carboxyphenyl)-5-(4-chlorophenyl)oxazole
• 英文别名: 4-(5-(4-chlorophenyl)oxazol-2-yl)benzoic acid；4-[5-(4-Chlorophenyl)-1,3-oxazol-2-yl]benzoic acid
• CAS: 108783-77-3
• 化学式: C₁₆H₁₀ClNO₃
• 分子量: 299.713
• InChiKey: VURLUTOWWPSBFJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.3
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(4-Carboxyphenyl)-5-(4-chlorophenyl)oxazole 在 氯化亚砜 作用下， 生成 Acid Chloride of 2-(4-Carboxyphenyl)-5-(4-chlorophenyl)oxazole
  参考文献：
  名称：

  4-（5-芳基恶唑基-2）苯甲酸及其衍生物的合成，光谱和发光性质

  摘要：

  DOI：

  10.1007/bf00478139
• 作为产物：
  描述：

  methyl 4-((2-(4-chlorophenyl)-2-oxoethyl)carbamoyl)benzoate 在 sodium hydroxide 、 硫酸 作用下， 以 丙酮 为溶剂， 反应 5.0h， 生成 2-(4-Carboxyphenyl)-5-(4-chlorophenyl)oxazole
  参考文献：
  名称：

  4-（5-芳基恶唑基-2）苯甲酸及其衍生物的合成，光谱和发光性质

  摘要：

  DOI：

  10.1007/bf00478139

文献信息

• Compounds for Nonsense Suppression, and Methods for Their Use
  申请人：Almstead Neil G.

  公开号：US20090253699A1

  公开（公告）日：2009-10-08

  The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.

  本发明涉及使用本发明的化合物或组合物治疗或预防与mRNA中无意义突变相关的疾病的方法、化合物和组合物。更具体地，本发明涉及用于抑制与mRNA中无意义突变相关的早期翻译终止的方法、化合物和组合物。
• METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCICATED THEREWITH
  申请人：Almstead Neil G.

  公开号：US20110046136A1

  公开（公告）日：2011-02-24

  The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene.

  本发明涉及由核酸序列编码的功能性蛋白质，其中包括一个无意义突变。本发明还涉及用于生产由包含无意义突变的核酸序列编码的功能性蛋白质的方法，以及利用这些蛋白质预防、管理和/或治疗与基因中的无意义突变相关的疾病。
• METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCIATED THEREWITH
  申请人：PTC THERAPEUTICS, INC

  公开号：US20160199357A1

  公开（公告）日：2016-07-14

  The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene.

  本发明涉及由包含无意义突变的核酸序列编码的功能蛋白质。本发明还涉及用于生产由包含无意义突变的核酸序列编码的功能蛋白质的方法，并使用这些蛋白质预防、管理和/或治疗与基因中的无意义突变相关的疾病。
• Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
  申请人：PTC Therapeutics, Inc.

  公开号：EP2301536A1

  公开（公告）日：2011-03-30

  The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.

  本发明涉及通过施用本发明的化合物或组合物治疗或预防与 mRNA 中无义突变相关的疾病的方法、化合物和组合物。更具体地说，本发明涉及抑制与 mRNA 中无义突变相关的过早翻译终止的方法、化合物和组合物。
• Compounds for nonsense suppression, and methods for their use
  申请人：PTC Therapeutics, Inc.

  公开号：EP2301538A1

  公开（公告）日：2011-03-30

  The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.

  本发明涉及通过施用本发明的化合物或组合物治疗或预防与 mRNA 中无义突变相关的疾病的方法、化合物和组合物。更具体地说，本发明涉及抑制与 mRNA 中无义突变相关的过早翻译终止的方法、化合物和组合物。